-
1
-
-
68449099413
-
Regulatory T cells: major players in the tumor microenvironment
-
Beyer M, Schultze JL (2009). Regulatory T cells: major players in the tumor microenvironment. Curr Pharm Des, 15, 1879-92.
-
(2009)
Curr Pharm Des
, vol.15
, pp. 1879-1892
-
-
Beyer, M.1
Schultze, J.L.2
-
2
-
-
67651160649
-
CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages
-
DeNardo DG, Barreto JB, Andreu P, et al (2009). CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell, 16, 91-102.
-
(2009)
Cancer Cell
, vol.16
, pp. 91-102
-
-
DeNardo, D.G.1
Barreto, J.B.2
Andreu, P.3
-
3
-
-
42649115767
-
Th17 cells in development: an updated view of their molecular identity and genetic programming
-
Dong C (2008). Th17 cells in development: an updated view of their molecular identity and genetic programming. N at Rev Imm unol, 8, 337-48.
-
(2008)
N at Rev Imm unol
, vol.8
, pp. 337-348
-
-
Dong, C.1
-
4
-
-
79955949234
-
Chemoprevention by Prunella vulgaris L. extract of non-small cell lung cancer via promoting apoptosis and regulating the cell cycle
-
Feng L, Jia X, Zhu M, et al (2010). Chemoprevention by Prunella vulgaris L. extract of non-small cell lung cancer via promoting apoptosis and regulating the cell cycle. Asian Pac J Cancer Prev, 11, 1355-8.
-
(2010)
Asian Pac J Cancer Prev
, vol.11
, pp. 1355-1358
-
-
Feng, L.1
Jia, X.2
Zhu, M.3
-
5
-
-
0038155128
-
Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T cell levels in patients with melanoma
-
Gray CP, Arosio P, Hersey P (2003). Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T cell levels in patients with melanoma. Clin Cancer Res, 9, 2551-9.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 2551-2559
-
-
Gray, C.P.1
Arosio, P.2
Hersey, P.3
-
6
-
-
0021826670
-
Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+ 2- T cells. Tumor eradication does not require participation of cytotoxic T cells.
-
Greenberg PD, Kern DE, Cheever MA (1985). Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+, 2- T cells. Tumor eradication does not require participation of cytotoxic T cells. J Exp Med, 161, 1122-34.
-
(1985)
J Exp Med
, vol.161
, pp. 1122-1134
-
-
Greenberg, P.D.1
Kern, D.E.2
Cheever, M.A.3
-
7
-
-
33749317518
-
Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions
-
Hiraoka N, Onozato K, KosugeT, et al (2006). Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res, 12, 5423-34.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 5423-5434
-
-
Hiraoka, N.1
Onozato, K.2
Kosuge, T.3
-
8
-
-
69449092647
-
T cell supp ression by naturally occurring HLA2G2exp ressing regulatory CD4+ T cells is IL-10- dependent and reversible
-
Huang YH, Zozulya AL, Weidenfeller C, Schwab N, Wiendl H (2009). T cell supp ression by naturally occurring HLA2G2exp ressing regulatory CD4+ T cells is IL-10- dependent and reversible. J Leu koc Biol, 86, 273-81.
-
(2009)
J Leu koc Biol
, vol.86
, pp. 273-281
-
-
Huang, Y.H.1
Zozulya, A.L.2
Weidenfeller, C.3
Schwab, N.4
Wiendl, H.5
-
9
-
-
45549099784
-
Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1
-
Hunder NN, Wallen H, Cao J, et al (2008). Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N Engl J Med, 358, 2698-703.
-
(2008)
N Engl J Med
, vol.358
, pp. 2698-2703
-
-
Hunder, N.N.1
Wallen, H.2
Cao, J.3
-
10
-
-
33847384529
-
FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis
-
Kobayashi N, Hiraoka N, Yamagami W, et al (2007). FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin CancerRes, 13, 902-11.
-
(2007)
Clin CancerRes
, vol.13
, pp. 902-911
-
-
Kobayashi, N.1
Hiraoka, N.2
Yamagami, W.3
-
11
-
-
33744457276
-
CD4(+)CD25 high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers
-
Kono K, Kawaida H, TakahashiA, et al (2006). CD4(+)CD25 high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol Immunother, 55, 1064-71.
-
(2006)
Cancer Immunol Immunother
, vol.55
, pp. 1064-1071
-
-
Kono, K.1
Kawaida, H.2
Takahashi, A.3
-
13
-
-
33751371759
-
Tumor-derived CD4+CD25+regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10
-
Larmonier N, Marron M, Zeng Y, et al (2007). Tumor-derived CD4+CD25+regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10.Cancer Immunol Immunothe, 56, 48-59.
-
(2007)
Cancer Immunol Immunothe
, vol.56
, pp. 48-59
-
-
Larmonier, N.1
Marron, M.2
Zeng, Y.3
-
14
-
-
44149100809
-
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas
-
Le Gouvello S, Bastuji-Garin S, Aloulou N, et al (2008). High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut, 57, 772-9.
-
(2008)
Gut
, vol.57
, pp. 772-779
-
-
Le Gouvello, S.1
Bastuji-Garin, S.2
Aloulou, N.3
-
15
-
-
77952391928
-
Tumor regulatory T cells potently abrogate antitumor immunity [J]
-
Liu Z, Kim JH, Falo LD Jr, You Z (2009). Tumor regulatory T cells potently abrogate antitumor immunity [J]. J Immunol [182,] 6160-7.
-
(2009)
J Immunol
, vol.182
, pp. 6160-6167
-
-
Liu, Z.1
Kim, J.H.2
Falo Jr., L.D.3
You, Z.4
-
16
-
-
27544465354
-
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
-
Park H, Li Z, Yang XO, et a1 (2005). A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat immunol, 6, 1133-41.
-
(2005)
Nat immunol
, vol.6
, pp. 1133-1141
-
-
Park, H.1
Li, Z.2
Yang, X.O.3
-
17
-
-
70249100293
-
Heterogeneity of CD4+memory T cells: functional modules for tailored immunity
-
Sallusto F et al (2009). Heterogeneity of CD4+memory T cells: functional modules for tailored immunity. Eur J Immunol, 39, 2076-82
-
(2009)
Eur J Immunol
, vol.39
, pp. 2076-2082
-
-
Sallusto, F.1
-
18
-
-
84863289521
-
Up-regulation of GTSE1 lacks a relationship with clinical data in lung cancer
-
Tian T, Zhang Z, Fei F, et al (2011). Up-regulation of GTSE1 lacks a relationship with clinical data in lung cancer. Asian Pac J Cancer Prev, 12, 2039-43.
-
(2011)
Asian Pac J Cancer Prev
, vol.12
, pp. 2039-2043
-
-
Tian, T.1
Zhang, Z.2
Fei, F.3
-
19
-
-
70249100293
-
TGFbeta in the c geneity of CD4+memory T cells: functional modules for tailored immunity
-
Veldhoen M, Hocking RJ, Atkins CJ, et a1 (2009). TGFbeta in the c geneity of CD4+memory T cells: functional modules for tailored immunity. Eur J Immunol, 39, 2076-82.
-
(2009)
Eur J Immunol
, vol.39
, pp. 2076-2082
-
-
Veldhoen, M.1
Hocking, R.J.2
Atkins, C.J.3
-
20
-
-
33847125247
-
Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression
-
Wan YY, Flavell RA (2007).Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature, 445, 766-70.
-
(2007)
Nature
, vol.445
, pp. 766-770
-
-
Wan, Y.Y.1
Flavell, R.A.2
-
21
-
-
53649086793
-
T cell mediated help against tumors
-
Wieder T, Braumüller H, Kneilling M, et al (2008). T cell mediated help against tumors. Cell Cycle, 7, 2974-7
-
(2008)
Cell Cycle
, vol.7
, pp. 2974-2977
-
-
Wieder, T.1
Braumüller, H.2
Kneilling, M.3
-
22
-
-
34247271308
-
Maintenance of the Foxp3- dependent developmental program in mature regulatory T cells requires continued expression of Foxp3
-
Williams LM, Rudensky AY (2007). Maintenance of the Foxp3- dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol, 8, 277-84.
-
(2007)
Nat Immunol
, vol.8
, pp. 277-284
-
-
Williams, L.M.1
Rudensky, A.Y.2
-
23
-
-
38349136823
-
Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokines
-
Winter H, van Den Engel NK, Rüttinger D, et al (2007). Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokines. J Transl Med, 5, 56.
-
(2007)
J Transl Med
, vol.5
, pp. 56
-
-
Winter, H.1
van Den Engel, N.K.2
Rüttinger, D.3
-
24
-
-
0035874949
-
Regulatory CD4(+) CD25(+) T cells in tumors from patients with early-stage NSCLC and late-stage ovarian cancer
-
Woo EY, Chu CS, GoletzTJ, et al (2001). Regulatory CD4(+) CD25(+) T cells in tumors from patients with early-stage NSCLC and late-stage ovarian cancer. CancerRes, 61, 4766-72.
-
(2001)
CancerRes
, vol.61
, pp. 4766-4772
-
-
Woo, E.Y.1
Chu, C.S.2
Goletz, T.J.3
-
25
-
-
48849101281
-
The prevalence of Th17 cells in patients with gastric cancer
-
Zhang B, Rong G, Wei H, et al (2008). The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun, 374, 533-7.
-
(2008)
Biochem Biophys Res Commun
, vol.374
, pp. 533-537
-
-
Zhang, B.1
Rong, G.2
Wei, H.3
-
26
-
-
64549108462
-
Increased intratumoral IL-17 producing cells correlate with poor survival in hepatocellular carcinoma patients
-
Zhang JP, Yan J, Xu J, et al (2009). Increased intratumoral IL-17 producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol, 50, 980-9.
-
(2009)
J Hepatol
, vol.50
, pp. 980-989
-
-
Zhang, J.P.1
Yan, J.2
Xu, J.3
|